00014035682022Q3--01-28false0001403568us-gaap:TreasuryStockCommonMember2022-07-312022-10-290001403568us-gaap:TreasuryStockCommonMember2022-05-012022-07-300001403568us-gaap:TreasuryStockCommonMember2022-01-302022-04-300001403568us-gaap:TreasuryStockCommonMember2021-08-012021-10-300001403568us-gaap:TreasuryStockCommonMember2021-05-022021-07-310001403568us-gaap:TreasuryStockCommonMember2021-01-312021-05-010001403568ulta:ShareRepurchaseProgram2022Member2022-03-310001403568ulta:ShareRepurchaseProgram2020Member2020-03-120001403568us-gaap:TreasuryStockCommonMember2022-10-290001403568us-gaap:RetainedEarningsMember2022-10-290001403568us-gaap:AdditionalPaidInCapitalMember2022-10-290001403568us-gaap:TreasuryStockCommonMember2022-07-300001403568us-gaap:RetainedEarningsMember2022-07-300001403568us-gaap:AdditionalPaidInCapitalMember2022-07-300001403568us-gaap:TreasuryStockCommonMember2022-04-300001403568us-gaap:RetainedEarningsMember2022-04-300001403568us-gaap:AdditionalPaidInCapitalMember2022-04-3000014035682022-04-300001403568us-gaap:TreasuryStockCommonMember2022-01-290001403568us-gaap:RetainedEarningsMember2022-01-290001403568us-gaap:AdditionalPaidInCapitalMember2022-01-290001403568us-gaap:TreasuryStockCommonMember2021-10-300001403568us-gaap:RetainedEarningsMember2021-10-300001403568us-gaap:AdditionalPaidInCapitalMember2021-10-300001403568us-gaap:TreasuryStockCommonMember2021-07-310001403568us-gaap:RetainedEarningsMember2021-07-310001403568us-gaap:AdditionalPaidInCapitalMember2021-07-310001403568us-gaap:TreasuryStockCommonMember2021-05-010001403568us-gaap:RetainedEarningsMember2021-05-010001403568us-gaap:AdditionalPaidInCapitalMember2021-05-0100014035682021-05-010001403568us-gaap:TreasuryStockCommonMember2021-01-300001403568us-gaap:RetainedEarningsMember2021-01-300001403568us-gaap:AdditionalPaidInCapitalMember2021-01-300001403568us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-300001403568stpr:WY2022-10-290001403568stpr:WV2022-10-290001403568stpr:WI2022-10-290001403568stpr:WA2022-10-290001403568stpr:VT2022-10-290001403568stpr:VA2022-10-290001403568stpr:UT2022-10-290001403568stpr:TX2022-10-290001403568stpr:TN2022-10-290001403568stpr:SD2022-10-290001403568stpr:SC2022-10-290001403568stpr:RI2022-10-290001403568stpr:PA2022-10-290001403568stpr:OR2022-10-290001403568stpr:OK2022-10-290001403568stpr:OH2022-10-290001403568stpr:NY2022-10-290001403568stpr:NV2022-10-290001403568stpr:NM2022-10-290001403568stpr:NJ2022-10-290001403568stpr:NH2022-10-290001403568stpr:NE2022-10-290001403568stpr:ND2022-10-290001403568stpr:NC2022-10-290001403568stpr:MT2022-10-290001403568stpr:MS2022-10-290001403568stpr:MO2022-10-290001403568stpr:MN2022-10-290001403568stpr:MI2022-10-290001403568stpr:ME2022-10-290001403568stpr:MD2022-10-290001403568stpr:MA2022-10-290001403568stpr:LA2022-10-290001403568stpr:KY2022-10-290001403568stpr:KS2022-10-290001403568stpr:IN2022-10-290001403568stpr:IL2022-10-290001403568stpr:ID2022-10-290001403568stpr:IA2022-10-290001403568stpr:HI2022-10-290001403568stpr:GA2022-10-290001403568stpr:FL2022-10-290001403568stpr:DE2022-10-290001403568stpr:CT2022-10-290001403568stpr:CO2022-10-290001403568stpr:CA2022-10-290001403568stpr:AZ2022-10-290001403568stpr:AR2022-10-290001403568stpr:AL2022-10-290001403568stpr:AK2022-10-290001403568us-gaap:RetainedEarningsMember2022-07-312022-10-290001403568us-gaap:RetainedEarningsMember2022-05-012022-07-300001403568us-gaap:RetainedEarningsMember2022-01-302022-04-300001403568us-gaap:RetainedEarningsMember2021-08-012021-10-300001403568us-gaap:RetainedEarningsMember2021-05-022021-07-310001403568us-gaap:RetainedEarningsMember2021-01-312021-05-010001403568ulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-01-302022-10-290001403568us-gaap:RevolvingCreditFacilityMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-10-290001403568us-gaap:LetterOfCreditMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-10-290001403568us-gaap:RevolvingCreditFacilityMember2022-10-290001403568us-gaap:RevolvingCreditFacilityMember2022-01-290001403568us-gaap:RevolvingCreditFacilityMember2021-10-300001403568us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-312021-05-010001403568us-gaap:FairValueInputsLevel2Memberus-gaap:NonqualifiedPlanMember2022-10-290001403568us-gaap:FairValueInputsLevel2Memberus-gaap:NonqualifiedPlanMember2022-01-290001403568us-gaap:FairValueInputsLevel2Memberus-gaap:NonqualifiedPlanMember2021-10-300001403568us-gaap:RestrictedStockUnitsRSUMember2022-10-290001403568us-gaap:PerformanceSharesMember2022-10-290001403568us-gaap:EmployeeStockOptionMember2022-10-290001403568srt:MinimumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Memberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-302022-10-290001403568srt:MinimumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Memberus-gaap:BaseRateMember2022-01-302022-10-290001403568srt:MaximumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Memberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-302022-10-290001403568srt:MaximumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Memberus-gaap:BaseRateMember2022-01-302022-10-2900014035682022-07-3000014035682021-07-310001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-07-312022-10-290001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-07-312022-10-290001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-07-312022-10-290001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-07-312022-10-290001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-07-312022-10-290001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-07-312022-10-290001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-07-312022-10-290001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-10-290001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-10-290001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-10-290001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-10-290001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-10-290001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-10-290001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-302022-10-290001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-08-012021-10-300001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-08-012021-10-300001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-08-012021-10-300001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-08-012021-10-300001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-08-012021-10-300001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-08-012021-10-300001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-08-012021-10-300001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-10-300001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-10-300001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-10-300001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-10-300001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-10-300001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-10-300001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-312021-10-300001403568us-gaap:CommonStockMember2022-10-290001403568us-gaap:CommonStockMember2022-07-300001403568us-gaap:CommonStockMember2022-04-300001403568us-gaap:CommonStockMember2022-01-290001403568us-gaap:CommonStockMember2021-10-300001403568us-gaap:CommonStockMember2021-07-310001403568us-gaap:CommonStockMember2021-05-010001403568us-gaap:CommonStockMember2021-01-3000014035682021-01-300001403568us-gaap:RestrictedStockUnitsRSUMember2022-07-312022-10-290001403568us-gaap:PerformanceSharesMember2022-07-312022-10-290001403568us-gaap:EmployeeStockOptionMember2022-07-312022-10-290001403568us-gaap:RestrictedStockUnitsRSUMember2022-01-302022-10-290001403568us-gaap:PerformanceSharesMember2022-01-302022-10-290001403568us-gaap:EmployeeStockOptionMember2022-01-302022-10-290001403568us-gaap:RestrictedStockUnitsRSUMember2021-08-012021-10-300001403568us-gaap:PerformanceSharesMember2021-08-012021-10-300001403568us-gaap:EmployeeStockOptionMember2021-08-012021-10-300001403568us-gaap:RestrictedStockUnitsRSUMember2021-01-312021-10-300001403568us-gaap:PerformanceSharesMember2021-01-312021-10-300001403568us-gaap:EmployeeStockOptionMember2021-01-312021-10-3000014035682022-10-2900014035682022-01-2900014035682021-10-300001403568us-gaap:CommonStockMember2022-07-312022-10-290001403568us-gaap:AdditionalPaidInCapitalMember2022-07-312022-10-290001403568us-gaap:CommonStockMember2022-05-012022-07-300001403568us-gaap:AdditionalPaidInCapitalMember2022-05-012022-07-3000014035682022-05-012022-07-300001403568us-gaap:CommonStockMember2022-01-302022-04-300001403568us-gaap:AdditionalPaidInCapitalMember2022-01-302022-04-3000014035682022-01-302022-04-300001403568us-gaap:CommonStockMember2021-08-012021-10-300001403568us-gaap:AdditionalPaidInCapitalMember2021-08-012021-10-300001403568us-gaap:CommonStockMember2021-05-022021-07-310001403568us-gaap:AdditionalPaidInCapitalMember2021-05-022021-07-3100014035682021-05-022021-07-310001403568us-gaap:CommonStockMember2021-01-312021-05-010001403568us-gaap:AdditionalPaidInCapitalMember2021-01-312021-05-0100014035682021-01-312021-05-010001403568us-gaap:RevolvingCreditFacilityMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-01-302022-10-2900014035682022-08-162022-08-1600014035682022-07-312022-10-2900014035682021-08-012021-10-300001403568srt:MinimumMemberulta:SecondAmendedAndRestatedLoanAgreement23August2017Member2022-01-302022-10-2900014035682021-01-312021-10-3000014035682022-11-2800014035682022-01-302022-10-29xbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:sharesulta:stateulta:store

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended October 29, 2022

or

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _____________ to _____________

Commission File Number: 001-33764

ULTA BEAUTY, INC.

(Exact name of Registrant as specified in its charter)


incorporation or organization)


Identification No.)

Delaware

(State or other jurisdiction of
incorporation or organization)

38-4022268

(I.R.S. Employer
Identification No.)

1000 Remington Blvd., Suite 120

Bolingbrook, Illinois

(Address of principal executive offices)

60440

(Zip code)

Registrant’s telephone number, including area code: (630) 410-4800

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.01 per share

ULTA

The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer      Accelerated filer      Non-accelerated filer      Smaller reporting company       Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  No

The number of shares of the registrant’s common stock, par value $0.01 per share, outstanding as of November 28, 2022 was 50,880,771 shares.

Table of Contents

ULTA BEAUTY, INC.

TABLE OF CONTENTS

Part I - Financial Information

Item 1.    Financial Statements

Consolidated Balance Sheets

3

Consolidated Statements of Income

4

Consolidated Statements of Cash Flows

5

Consolidated Statements of Stockholders’ Equity

6

Notes to Consolidated Financial Statements

8

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

15

Item 3.    Quantitative and Qualitative Disclosures about Market Risk

24

Item 4.    Controls and Procedures

25

Part II - Other Information

25

Item 1.    Legal Proceedings

25

Item 1A. Risk Factors

25

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

26

Item 3.    Defaults Upon Senior Securities

26

Item 4.    Mine Safety Disclosures

26

Item 5.    Other Information

26

Item 6.    Exhibits

27

SIGNATURES

28

2

Table of Contents

Part I - Financial Information

Item 1.Financial Statements

Ulta Beauty, Inc.

Consolidated Balance Sheets

October 29,

January 29,

October 30,

(In thousands, except per share data)

    

2022

    

2022

    

2021

Assets

(Unaudited)

(Unaudited)

Current assets:

Cash and cash equivalents

$

250,628

$

431,560

$

605,053

Receivables, net

200,304

233,682

169,212

Merchandise inventories, net

2,114,669

1,499,218

1,916,343

Prepaid expenses and other current assets

137,642

110,814

105,584

Prepaid income taxes

42,572

5,909

37,501

Total current assets

2,745,815

2,281,183

2,833,693

Property and equipment, net

967,039

914,476

908,665

Operating lease assets

1,556,940

1,482,256

1,464,533

Goodwill

10,870

10,870

10,870

Other intangible assets, net

844

1,538

1,770

Deferred compensation plan assets

31,529

38,409

36,403

Other long-term assets

18,512

35,647

31,833

Total assets

$

5,331,549

$

4,764,379

$

5,287,767

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$

647,117

$

552,730

$

747,451

Accrued liabilities

462,773

364,797

329,672

Deferred revenue

312,132

353,579

272,628

Current operating lease liabilities

275,749

274,118

274,365

Accrued income taxes

12,786

Total current liabilities

1,697,771

1,558,010

1,624,116

Non-current operating lease liabilities

1,621,252

1,572,638

1,565,921

Deferred income taxes

38,627

39,693

67,267

Other long-term liabilities

51,644

58,665

43,663

Total liabilities

3,409,294

3,229,006

3,300,967

Commitments and contingencies (Note 6)

Stockholders' equity:

Common stock, $0.01 par value, 400,000 shares authorized; 51,785, 53,049, and 54,907 shares issued; 51,029, 52,311, and 54,170 shares outstanding; at October 29, 2022 (unaudited), January 29, 2022, and October 30, 2021 (unaudited), respectively

517

530

549

Treasury stock-common, at cost

(60,218)

(53,478)

(53,312)

Additional paid-in capital

998,816

934,945

915,814

Retained earnings

983,140

653,376

1,123,749

Total stockholders’ equity

1,922,255

1,535,373

1,986,800

Total liabilities and stockholders’ equity

$

5,331,549

$

4,764,379

$

5,287,767

See accompanying notes to consolidated financial statements.

3

Table of Contents

Ulta Beauty, Inc.

Consolidated Statements of Income

(Unaudited)

13 Weeks Ended

39 Weeks Ended

October 29,

October 30,

October 29,

October 30,

(In thousands, except per share data)

    

2022

2021

2022

2021

Net sales

$

2,338,793

$

1,995,775

$

6,981,807

$

5,901,501

Cost of sales

1,375,976

1,206,301

4,149,800

3,560,276

Gross profit

962,817

789,474

2,832,007

2,341,225

Selling, general and administrative expenses

597,164

503,403

1,632,593

1,411,577

Pre-opening expenses

3,797

1,832

8,422

7,778

Operating income

361,856

284,239

1,190,992

921,870

Interest expense (income), net

(849)

413

(556)

1,196

Income before income taxes

362,705

283,826

1,191,548

920,674

Income tax expense

88,120

68,537

289,891

224,203

Net income

$

274,585

$

215,289

$

901,657

$

696,471

Net income per common share:

Basic

$

5.37

$

3.97

$

17.45

$

12.68

Diluted

$

5.34

$

3.94

$

17.35

$

12.60

Weighted average common shares outstanding:

Basic

51,131

54,291

51,663

54,921

Diluted

51,418

54,660

51,962

55,280

See accompanying notes to consolidated financial statements.

4

Table of Contents

Ulta Beauty, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

39 Weeks Ended

October 29,

October 30,

(In thousands)

    

2022

    

2021

Operating activities

Net income

$

901,657

$

696,471

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

182,182

204,734

Non-cash lease expense

222,548

206,017

Deferred income taxes

(1,066)

1,908

Stock-based compensation expense

32,554

38,217

Loss on disposal of property and equipment

3,892

3,357

Change in operating assets and liabilities:

Receivables

33,378

23,897

Merchandise inventories

(615,451)

(748,128)

Prepaid expenses and other current assets

(26,828)

1,818

Income taxes

(49,446)

(80,027)

Accounts payable

94,214

266,104

Accrued liabilities

64,164

24,482

Deferred revenue

(41,447)

(1,755)

Operating lease liabilities

(246,988)

(222,451)

Other assets and liabilities

20,063

213

Net cash provided by operating activities

573,426

414,857

Investing activities

Capital expenditures

(203,961)

(108,418)

Other investments

(3,068)

Net cash used in investing activities

(207,029)

(108,418)

Financing activities

Repurchase of common shares

(571,908)

(762,167)

Stock options exercised

31,319

30,297

Purchase of treasury shares

(6,740)

(15,511)

Net cash used in financing activities

(547,329)

(747,381)

Effect of exchange rate changes on cash and cash equivalents

(56)

Net decrease in cash and cash equivalents

(180,932)

(440,998)

Cash and cash equivalents at beginning of period

431,560

1,046,051

Cash and cash equivalents at end of period

$

250,628

$

605,053

Supplemental information

Cash paid for interest

$

1,598

$

1,594

Income taxes paid, net of refunds

    

339,290

301,312

Non-cash capital expenditures

33,982

13,148

See accompanying notes to consolidated financial statements.

5

Table of Contents

Ulta Beauty, Inc.

Consolidated Statements of Stockholders’ Equity

(Unaudited)

Treasury -

Common Stock

Common Stock

Additional

Total

Issued

Treasury

Paid-In

Retained

Stockholders'

(In thousands)

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Earnings

    

Equity

Balance – January 29, 2022

53,049

$

530

(738)

$

(53,478)

$

934,945

$

653,376

$

1,535,373

Net income

331,395

331,395

Stock-based compensation

10,356

10,356

Stock options exercised and other awards

73

1

6,501

6,502

Purchase of treasury shares

(14)

(5,172)

(5,172)

Repurchase of common shares

(332)

(3)

(132,831)

(132,834)

Balance – April 30, 2022

52,790

$

528

(752)

$

(58,650)

$

951,802

$

851,940

$

1,745,620

Net income

295,677

295,677

Stock-based compensation

12,519

12,519

Stock options exercised and other awards

95

1

18,018

18,019

Purchase of treasury shares

(3)

(1,153)

(1,153)

Repurchase of common shares

(798)

(8)

(301,606)

(301,614)

Balance – July 30, 2022

52,087

$

521

(755)

$

(59,803)

$

982,339

$

846,011

$

1,769,068

Net income

274,585

274,585

Stock-based compensation

9,679

9,679

Stock options exercised and other awards

38

6,798

6,798

Purchase of treasury shares

(1)

(415)

(415)

Repurchase of common shares

(340)

(4)

(137,456)

(137,460)

Balance – October 29, 2022

51,785

$

517

(756)

$

(60,218)

$

998,816

$

983,140

$

1,922,255

See accompanying notes to consolidated financial statements.

6

Table of Contents

Ulta Beauty, Inc.

Consolidated Statements of Stockholders’ Equity

(Unaudited)

Treasury -

Accumulated

Common Stock

Common Stock

Additional

Other

Total

Issued

Treasury

Paid-In

Retained

Comprehensive

Stockholders'

(In thousands)

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Earnings

    

Income (Loss)

    

Equity

Balance – January 30, 2021

56,952

$

569

(692)

$

(37,801)

$

847,303

$

1,189,422

$

56

$

1,999,549

Net income

230,289

230,289

Stock-based compensation

8,978

8,978

Foreign currency translation adjustments

(56)

(56)

Stock options exercised and other awards

94

1

5,031

5,032

Purchase of treasury shares

(21)

(6,766)

(6,766)

Repurchase of common shares

(1,243)

(12)

(392,297)

(392,309)

Balance – May 1, 2021

55,803

$

558

(713)

$

(44,567)

$

861,312

$

1,027,414

$

$

1,844,717

Net income

250,893

250,893

Stock-based compensation

10,119

10,119

Stock options exercised and other awards

104

1

17,775

17,776

Purchase of treasury shares

(1)

(208)

(208)

Repurchase of common shares

(747)

(8)

(243,476)

(243,484)

Balance – July 31, 2021

55,160

$

551

(714)

$

(44,775)

$

889,206

$

1,034,831

$

$

1,879,813

Net income

215,289

215,289

Stock-based compensation

19,120

19,120

Stock options exercised and other awards

87

1

7,488

7,489

Purchase of treasury shares

(23)

(8,537)

(8,537)

Repurchase of common shares

(340)

(3)

(126,371)

(126,374)

Balance – October 30, 2021

54,907

$

549

(737)

$

(53,312)

$

915,814

$

1,123,749

$

$

1,986,800

See accompanying notes to consolidated financial statements.

7

Table of Contents

Ulta Beauty, Inc.

Notes to Consolidated Financial Statements

(In thousands, except per share and store count data) (Unaudited)

1.Business and basis of presentation

Ulta Beauty, Inc. was founded in 1990 to operate specialty retail stores selling cosmetics, fragrance, haircare and skincare products, and related accessories and services. The stores also feature full-service salons. As used in these notes and throughout this Quarterly Report on Form 10-Q, all references to “we,” “us,” “our,” “Ulta Beauty,” or the “Company” refer to Ulta Beauty, Inc. and its consolidated subsidiaries.

As of October 29, 2022, the Company operated 1,343 stores across 50 states, as shown in the table below.

Number of

Number of

Location

    

stores

    

Location

    

stores

Alabama

24

Montana

6

Alaska

3

Nebraska

5

Arizona

32

Nevada

16

Arkansas

11

New Hampshire

8

California

166

New Jersey

44

Colorado

26

New Mexico

7

Connecticut

19

New York

52

Delaware

4

North Carolina

43

Florida

92

North Dakota

4

Georgia

43

Ohio

45

Hawaii

4

Oklahoma

21

Idaho

9

Oregon

18

Illinois

55

Pennsylvania

45

Indiana

25

Rhode Island

4

Iowa

11

South Carolina

24

Kansas

13

South Dakota

3

Kentucky

15

Tennessee

28

Louisiana

18

Texas

125

Maine

3

Utah

15

Maryland

28

Vermont

1

Massachusetts

24

Virginia

32

Michigan

49

Washington

37

Minnesota

19

West Virginia

7

Mississippi

12

Wisconsin

20

Missouri

25

Wyoming

3

Total

1,343

The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and the U.S. Securities and Exchange Commission’s Article 10, Regulation S-X. These financial statements were prepared on a consolidated basis to include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts, transactions, and unrealized profit were eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary to fairly state the financial position and results of operations and cash flows for the interim periods presented.

8

Table of Contents

The Company’s business is subject to seasonal fluctuation, with significant portions of net sales and net income being realized during the fourth quarter of the fiscal year due to the holiday selling season. The results for the 13 and 39 weeks ended October 29, 2022 are not necessarily indicative of the results to be expected for the fiscal year ending January 28, 2023, or for any other future interim period or for any future year, in particular as a result of the uncertainty around the continuing effects of the COVID-19 pandemic, geopolitical events, and inflationary cost pressures on future periods.

These unaudited interim consolidated financial statements and the related notes should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended January 29, 2022. All amounts are stated in thousands, with the exception of per share amounts and number of stores.

2.Summary of significant accounting policies

Information regarding significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Annual Report on Form 10-K for the year ended January 29, 2022. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Consolidated Financial Statements” in the Annual Report.

Fiscal quarter

The Company’s quarterly periods are the 13 weeks ending on the Saturday closest to April 30, July 31, October 31, and January 31. The third quarter in fiscal 2022 and 2021 ended on October 29, 2022 and October 30, 2021, respectively.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. Actual results could differ from those estimates. The Company considers its accounting policies relating to inventory valuations, vendor allowances, impairment of long-lived tangible and right-of-use assets, loyalty program and income taxes to be the most significant accounting policies that involve management estimates and judgments. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment, including those related to the impacts of the COVID-19 pandemic, geopolitical events, and inflationary cost pressures, will be reflected in the consolidated financial statements in future periods.

9

Table of Contents

3.Revenue

Net sales include retail stores and e-commerce merchandise sales as well as salon services and other revenue. Other revenue includes the private label and co-branded credit card programs, royalties derived from the partnership with Target Corporation, and deferred revenue related to the loyalty program and gift card breakage.

Disaggregated revenue

The following table sets forth the approximate percentage of net sales by primary category:

13 Weeks Ended  

39 Weeks Ended

October 29,

October 30,

October 29,

October 30,

(Percentage of net sales)

2022

2021

2022

2021

Cosmetics

44%

45%

43%

44%

Haircare products and styling tools

21%

21%

21%

20%

Skincare

16%

16%

17%

17%

Fragrance and bath

12%

12%

12%

12%

Services

4%

3%

4%

4%

Accessories and other

3%

3%

3%

3%

100%

100%

100%

100%

Deferred revenue

Deferred revenue primarily represents contract liabilities for the obligation to transfer additional goods or services to a guest for which the Company has received consideration, such as unredeemed Ultamate Rewards loyalty points and unredeemed Ulta Beauty gift cards. In addition, breakage on gift cards is recognized proportionately as redemption occurs.

The following table provides a summary of the changes included in deferred revenue during the 13 and 39 weeks ended October 29, 2022 and October 30, 2021:

13 Weeks Ended

39 Weeks Ended

October 29,

October 30,

October 29,

October 30,

(In thousands)

2022

2021

2022

    

2021

Beginning balance

$

305,913

$

256,227

$

345,206

$

269,032

Additions to contract liabilities (1)

97,521

92,074

224,938

201,106

Deductions to contract liabilities (2)

(99,443)

(85,078)

(266,153)

(206,915)

Ending balance

$

303,991

$

263,223

$

303,991

$

263,223

(1)Loyalty points and gift cards issued in the current period but not redeemed or expired.
(2)Revenue recognized in the current period related to the beginning liability.

Other amounts included in deferred revenue were $8,141 and $9,405 at October 29, 2022 and October 30, 2021, respectively.

4.Goodwill and other intangible assets

Goodwill, which represents the excess of cost over the fair value of net assets acquired, was $10,870 at October 29, 2022, January 29, 2022, and October 30, 2021. No additional goodwill was recognized during the 13 and 39 weeks ended October 29, 2022. The recoverability of goodwill is reviewed annually during the fourth quarter or more frequently if an event occurs or circumstances change that would indicate that impairment may exist.

10

Table of Contents

Other definite-lived intangible assets are amortized over their useful lives. The recoverability of intangible assets is reviewed whenever events or changes in circumstances indicate the carrying amount of such assets may not be recoverable.

5.Leases

The Company leases retail stores, distribution centers, fast fulfillment centers, corporate offices, and certain equipment under non-cancelable operating leases with various expiration dates through 2034. All leases are classified as operating leases and generally have initial lease terms of 10 years and, when determined applicable, include renewal options under substantially the same terms and conditions as the original leases. Leases do not contain any material residual value guarantees or material restrictive covenants.

Lease cost

The majority of operating lease cost relates to retail stores, distribution centers, and fast fulfillment centers and is classified within cost of sales. Operating lease cost for corporate offices is classified within selling, general and administrative expenses. Operating lease cost from the control date through store opening date is classified within pre-opening expenses.

The following table presents a summary of operating lease costs:

13 Weeks Ended

39 Weeks Ended

October 29,

October 30,

October 29,

October 30,

(In thousands)

2022

2021

2022

2021

Operating lease cost

$

80,371

$

77,976

$

240,366

$

233,488

Other information

The following table presents supplemental disclosures of cash flow information related to operating leases:

    

39 Weeks Ended

October 29,

October 30,

(In thousands)

    

2022

2021

Cash paid for operating lease liabilities (1)

$

286,016

$

275,016

Operating lease assets obtained in exchange for operating lease liabilities (non-cash)

297,232

165,936

(1)Excludes $21,347 and $24,570 related to cash received for tenant incentives for the 39 weeks ended October 29, 2022 and October 30, 2021, respectively.

6.Commitments and contingencies

The Company is involved in various legal proceedings that are incidental to the conduct of the business including both class action and single plaintiff litigation. In the opinion of management, the amount of any liability with respect to these proceedings, either individually or in the aggregate, will not have a material adverse effect on the consolidated financial position, results of operations or cash flows.

7.Debt

On March 11, 2020, the Company entered into Amendment No. 1 to the Second Amended and Restated Loan Agreement (as so amended, the Loan Agreement) with Wells Fargo Bank, National Association, as Administrative Agent, Collateral Agent and a Lender thereunder; Wells Fargo Bank, National Association and JPMorgan Chase Bank, N.A., as Lead Arrangers and Bookrunners; JPMorgan Chase Bank, N.A., as Syndication Agent and a Lender; PNC Bank, National Association, as Documentation Agent and a Lender; and the other lenders party thereto. The Loan Agreement matures on March 11, 2025, provides maximum revolving loans equal to the lesser of $1,000,000 or a percentage of eligible owned

11

Table of Contents

inventory and eligible owned receivables (which borrowing base may, at the election of the Company and satisfaction of certain conditions, include a percentage of qualified cash), contains a $50,000 subfacility for letters of credit and allows the Company to increase the revolving facility by an additional $100,000, subject to the consent by each lender and other conditions. The Loan Agreement contains a requirement to maintain a fixed charge coverage ratio of not less than 1.0 to 1.0 during such periods when availability under the Loan Agreement falls below a specified threshold. Substantially all of the Company’s assets are pledged as collateral for outstanding borrowings under the Loan Agreement. Outstanding borrowings bear interest, at the Company’s election, at either a base rate plus a margin of 0% to 0.125% or the London Interbank Offered Rate plus a margin of 1.125% to 1.250%, with such margins based on the Company’s borrowing availability, and the unused line fee is 0.20% per annum.

As of October 29, 2022, January 29, 2022, and October 30, 2021, there were no borrowings outstanding under the credit facility.

As of October 29, 2022, the Company was in compliance with all terms and covenants of the Loan Agreement.

8.Fair value measurements

The carrying value of cash and cash equivalents, accounts receivable, and accounts payable approximates their estimated fair values due to the short maturities of these instruments.

Fair value is measured using inputs from the three levels of the fair value hierarchy, which are described as follows:

Level 1 – observable inputs such as quoted prices for identical instruments in active markets.
Level 2 – inputs other than quoted prices in active markets that are observable either directly or indirectly through corroboration with observable market data.
Level 3 – unobservable inputs in which there is little or no market data, which would require the Company to develop its own assumptions.

As of October 29, 2022, January 29, 2022, and October 30, 2021, there were liabilities related to the non-qualified deferred compensation plan included in other long-term liabilities on the consolidated balance sheets of $34,839, $40,839, and $38,333, respectively. The liabilities are categorized as Level 2 as they are based on third-party reported values, which are based primarily on quoted market prices of underlying assets of the funds within the plan.

9.Stock-based compensation

Stock-based compensation expense is measured on the grant date based on the fair value of the award. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period for awards expected to vest. The estimated grant date fair value of stock options was determined using a Black-Scholes valuation model using the following weighted-average assumptions:

    

39 Weeks Ended

October 29,

October 30,

    

2022

    

2021

Volatility rate

 

49.0%

46.9%

Average risk-free interest rate

 

2.4%

0.4%

Average expected life (in years)

 

3.4

 

3.9

Dividend yield

 

None

 

None

The expected volatility is based on the historical volatility of the Company’s common stock. The risk-free interest rate is based on the United States Treasury yield curve in effect on the date of grant for the respective expected life of the option. The expected life represents the time the options granted are expected to be outstanding. The expected life of options granted is derived from historical data on Ulta Beauty stock option exercises. Forfeitures of stock options are estimated at the grant date based on historical rates of stock option activity and reduce the stock-based compensation expense recognized. The Company does not currently pay a regular dividend.

12

Table of Contents

The Company granted 48 and 61 stock options during the 39 weeks ended October 29, 2022 and October 30, 2021, respectively. Stock-based compensation expense for stock options was $1,646 and $2,712 for the 13 weeks ended October 29, 2022 and October 30, 2021, respectively. Stock-based compensation expense for stock options was $6,152 and $8,710 for the 39 weeks ended October 29, 2022 and October 30, 2021, respectively. The weighted-average grant date fair value of these stock options was $149.14 and $109.72 for the 39 weeks ended October 29, 2022 and October 30, 2021, respectively. At October 29, 2022, there was approximately $12,073 of unrecognized stock-based compensation expense related to unvested stock options.

There were 58 and 60 restricted stock units issued during the 39 weeks ended October 29, 2022 and October 30, 2021, respectively. Stock-based compensation expense for restricted stock units was $4,544 and $4,622 for the 13 weeks ended October 29, 2022 and October 30, 2021, respectively. Stock-based compensation expense for restricted stock units was $13,983 and $14,606 for the 39 weeks ended October 29, 2022 and October 30, 2021, respectively. At October 29, 2022, there was approximately $28,260 of unrecognized stock-based compensation expense related to restricted stock units.

There were 37 and 46 performance-based restricted stock units issued during the 39 weeks ended October 29, 2022 and October 30, 2021, respectively. Stock-based compensation expense for performance-based restricted stock units was $3,489 and $1,786 for the 13 weeks ended October 29, 2022 and October 30, 2021, respectively. Stock-based compensation expense for performance-based restricted stock units was $12,419 and $4,901 for the 39 weeks ended October 29, 2022 and October 30, 2021, respectively. At October 29, 2022, there was approximately $27,039 of unrecognized stock-based compensation expense related to performance-based restricted stock units.

10.Income taxes

Income tax expense reflects the federal statutory tax rate and the weighted average state statutory tax rate for the states in which the Company operates stores. Income tax expense of $88,120 for the 13 weeks ended October 29, 2022 represents an effective tax rate of 24.3%, compared to $68,537 of tax expense representing an effective tax rate of 24.1% for the 13 weeks ended October 30, 2021.

Income tax expense of $289,891 for the 39 weeks ended October 29, 2022 represents an effective tax rate of 24.3%, compared to $224,203 of tax expense representing an effective tax rate of 24.4% for the 39 weeks ended October 30, 2021.

On August 16, 2022, the Inflation Reduction Act of 2022 was enacted into law, which, among other things, introduces a 15% corporate alternative minimum tax on book income of certain large corporations and creates a 1% excise tax on net share repurchases. The corporate alternative minimum tax will be effective in fiscal 2024, and the excise tax applies to share repurchases made after December 31, 2022. The corporate alternative minimum tax and the excise tax are not expected to have a material impact on the consolidated financial statements.

13

Table of Contents

11.Net income per common share

The following is a reconciliation of net income and the number of shares of common stock used in the computation of net income per basic and diluted common share:

13 Weeks Ended

39 Weeks Ended

October 29,

October 30,

October 29,

October 30,

(In thousands, except per share data)

    

2022

    

2021

    

2022

    

2021

Numerator:

Net income

    

$

274,585

$

215,289

$

901,657

$

696,471

Denominator:

Weighted-average common shares – Basic

51,131

54,291

51,663

54,921

Dilutive effect of stock options and non-vested stock

287

369

299

359

Weighted-average common shares – Diluted

51,418

54,660

51,962

55,280

Net income per common share:

Basic

$

5.37

$

3.97

$

17.45

$

12.68

Diluted

$

5.34

$

3.94

$

17.35

$

12.60

The denominator for diluted net income per common share for the 13 weeks ended October 29, 2022 and October 30, 2021 excludes 50 and 144 employee stock options and restricted stock units, respectively, due to their anti-dilutive effects. The denominator for diluted net income per common share for the 39 weeks ended October 29, 2022 and October 30, 2021 excludes 119 and 173 employee stock options and restricted stock units, respectively, due to their anti-dilutive effects. Outstanding performance-based restricted stock units are included in the computation of dilutive shares only to the extent that the underlying performance conditions are satisfied prior to the end of the reporting period or would be considered satisfied if the end of the reporting period were the end of the related contingency period and the results would be dilutive under the treasury stock method.

12.Share repurchase program

In March 2020, the Board of Directors authorized a share repurchase program (the 2020 Share Repurchase Program) pursuant to which the Company could repurchase up to $1,600,000 of the Company’s common stock. The 2020 Share Repurchase Program authorization revoked the previously authorized but unused amount of $177,805 from the earlier share repurchase program. The 2020 Share Repurchase Program did not have an expiration date but provided for suspension or discontinuation at any time.

In March 2022, the Board of Directors authorized a new share repurchase program (the 2022 Share Repurchase Program) pursuant to which the Company may repurchase up to $2,000,000 of the Company’s common stock. The 2022 Share Repurchase Program revokes the previously authorized but unused amounts from the 2020 Share Repurchase Program. The 2022 Share Repurchase Program does not have an expiration date and may be suspended or discontinued at any time.

A summary of common stock repurchase activity is presented in the following table:

39 Weeks Ended  

October 29,

October 30,

(In thousands)

2022

    

2021

Shares repurchased

1,470

2,330

Total cost of shares repurchased

$

571,908

$

762,167

14

Table of Contents

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this quarterly report. This discussion contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect our current views with respect to, among other things, future events and financial performance. You can identify these forward-looking statements by the use of forward-looking words such as “outlook,” “believes,” “expects,” “plans,” “estimates,” “targets,” “strategies,” or other comparable words. Any forward-looking statements contained in this Form 10-Q are based upon our historical performance and on current plans, estimates, and expectations. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates, targets, strategies, or expectations contemplated by us will be achieved. Such forward-looking statements are subject to various risks and uncertainties, which include, without limitation:

changes in the overall level of consumer spending and volatility in the economy, including as a result of the COVID-19 pandemic and geopolitical events;
the impact of current inflationary cost pressures on payroll, benefits, supply chain, and other operating costs;
our ability to sustain our growth plans and successfully implement our long-range strategic and financial plan;
the ability to execute our operational excellence priorities, including continuous improvement, Project SOAR (our replacement enterprise resource planning platform), and supply chain optimization;
epidemics, pandemics or natural disasters that have and could continue to negatively impact sales;
our ability to gauge beauty trends and react to changing consumer preferences in a timely manner;
the possibility that we may be unable to compete effectively in our highly competitive markets;
the possibility that cybersecurity or information security breaches and other disruptions could compromise our information or result in the unauthorized disclosure of confidential information;
the possibility of material disruptions to our information systems;
the failure to maintain satisfactory compliance with applicable privacy and data protection laws and regulations;
the possibility that the capacity of our distribution and order fulfillment infrastructure and the performance of our distribution centers and fast fulfillment centers may not be adequate to support our expected future growth plans;
changes in the wholesale cost of our products;
a decline in operating results that has and may continue to lead to asset impairment and store closure charges;
the possibility that new store openings and existing locations may be impacted by developer or co-tenant issues;
our ability to attract and retain key executive personnel;
the impact of climate change on our business operations and/or supply chain;
our ability to successfully execute our common stock repurchase program or implement future common stock repurchase programs; and
other risk factors detailed in our public filings with the Securities and Exchange Commission (the SEC), including risk factors contained in Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended January 29, 2022, as such may be amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q (including this report).

Except to the extent required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

References in the following discussion to “we,” “us,” “our,” “Ulta Beauty,” the “Company,” and similar references mean Ulta Beauty, Inc. and its consolidated subsidiaries, unless otherwise expressly stated or the context otherwise requires.

Overview

We were founded in 1990 as a beauty retailer at a time when prestige, mass, and salon products were sold through distinct channels – department stores for prestige products; drug stores and mass merchandisers for mass products; and

15

Table of Contents

salons and authorized retail outlets for professional hair care products. We developed a unique specialty retail concept that offers a broad range of brands and price points, select beauty services, and a convenient and welcoming shopping environment. We define our target consumer as a beauty enthusiast, a consumer who is passionate about the beauty category, uses beauty for self-expression, experimentation and self-investment, and has high expectations for the shopping experience. We believe our strategy provides us with the competitive advantages that have contributed to our financial performance.

Today, we are the largest beauty retailer in the United States and the premier beauty destination for cosmetics, fragrance, skin care products, hair care products, and salon services. Key aspects of our business include: a differentiated assortment of more than 25,000 beauty products across a variety of categories and price points as well as a variety of beauty services, including salon services, in more than 1,300 stores predominantly located in convenient, high-traffic locations; engaging digital experiences delivered through our website, Ulta.com, and our mobile applications; our best-in-class loyalty program that enables members to earn points for every dollar spent on products and beauty services and provides us with deep, proprietary customer insights; and our ability to cultivate human connection with warm and welcoming guest experiences across all of our channels.

The continued growth of our business and any future increases in net sales, net income, and cash flows is dependent on our ability to execute our strategic priorities: 1) drive breakthrough and disruptive growth through an expanded definition of All Things Beauty; 2) evolve the omnichannel experience through connected physical and digital ecosystems, All In Your World; 3) expand and deepen our presence across the beauty journey, solidifying Ulta Beauty at the Heart of the Beauty Community; 4) drive operational excellence and optimization; 5) protect and cultivate our world-class culture and talent; and 6) expand our environmental and social impact. We believe the attractive and growing U.S. beauty products and salon services industry, the expanding definition of beauty and the role that omnichannel capabilities play in consumers’ lives, coupled with Ulta Beauty’s competitive strengths, position us to capture additional market share in the industry.

Comparable sales is a key metric that is monitored closely within the retail industry. Our comparable sales have fluctuated in the past, and we expect them to continue to fluctuate in the future. A variety of factors affect our comparable sales, including general U.S. economic conditions, changes in merchandise strategy or mix, and timing and effectiveness of our marketing activities, among others.

Over the long term, our growth strategy is to increase total net sales through growing our comparable sales, expanding omnichannel capabilities, and opening new stores. Long-term operating profit is expected to increase as a result of our efforts to optimize our real estate portfolio, expand merchandise margin, and leverage our fixed store costs with comparable sales increases and operating efficiencies, partially offset by incremental investments in people, systems, and supply chain required to support a 1,500 to 1,700 store chain in the U.S. with successful e-commerce and competitive omnichannel capabilities.

Current Trends

Impact of COVID-19

We closely monitor the continuing impact of COVID-19 on all facets of our business. While operations during the first three quarters of fiscal 2022 did not appear to be negatively impacted, the continuing COVID-19 pandemic could have negative impacts in the future. The extent of the impact of the pandemic on our future business and financial results will depend on, among other things, the potential temporary reclosing of certain stores, the potential temporary restrictions on certain store operating hours and/or in-store capacity, supply chain disruptions, increased freight costs and higher wholesale costs, the continued duration of the pandemic and any variants of the virus, the duration, timing and severity of the impact on consumer spending, the timing and effectiveness of vaccine distribution, vaccination rates, and how quickly and to what extent normal economic and operating conditions can resume.

Industry trends

Our research indicates that Ulta Beauty has captured meaningful market share across all categories over the last several years. However, the COVID-19 pandemic and its various impacts changed consumer behavior and consumption of

16

Table of Contents

beauty products due to the closures of offices, retail stores and other businesses and the significant decline in travel, entertainment and social gatherings. The overall beauty market declined in 2020 but stabilized in 2021, as consumers began to recover from the impacts of COVID-19. We remain confident that our differentiated and diverse business model, our commitment to strategic investments, and our highly engaged associates will continue to drive market share gains over the long term.

Impact of inflation and changing prices

Although we do not believe inflation had a material impact on our sales year to date, continued pressure from inflation could have an adverse impact on consumer spending and sales and could lead to an economic recession. Furthermore, inflationary pressures could negatively impact our ability to maintain current levels of gross margin and selling, general and administrative expenses as a percentage of net sales if the selling prices of our products do not increase with higher costs. In addition, inflation could materially increase the interest rates on any future debt.

Basis of presentation

The Company has one reportable segment, which includes retail stores, salon services, and e-commerce.  

We recognize merchandise revenue at the point of sale in our retail stores. E-commerce sales are recognized upon shipment or guest pickup of the merchandise based on meeting the transfer of control criteria. Retail store and e-commerce sales are recorded net of estimated returns. Shipping and handling are treated as costs to fulfill the contract and not a separate performance obligation. Accordingly, we recognize revenue for our single performance obligation related to online sales at the time control of the merchandise passes to the customer, which is at the time of shipment or guest pickup. We provide refunds for merchandise returns within 60 days from the original purchase date. State sales taxes are presented on a net basis as we consider our self a pass-through conduit for collecting and remitting state sales tax. Salon service revenue is recognized at the time the service is provided to the guest. Gift card sales revenue is deferred until the guest redeems the gift card. Company coupons and other incentives are recorded as a reduction of net sales. Other revenue includes the private label and co-branded credit card programs, royalties derived from the partnership with Target Corporation, and deferred revenue related to the loyalty program and gift card breakage.

Comparable sales reflect sales for stores beginning on the first day of the 14th month of operation. Therefore, a store is included in our comparable store base on the first day of the period after one year of operations plus the initial one-month grand opening period. Non-comparable store sales include sales from new stores that have not yet completed their 13th month of operation and stores that were closed for part or all of the period in either year. Remodeled stores are included in comparable sales unless the store was closed for a portion of the current or prior period. Comparable sales include retail sales, salon services, and e-commerce. There may be variations in the way in which some of our competitors and other retailers calculate comparable or same store sales.

Measuring comparable sales allows us to evaluate the performance of our store base as well as several other aspects of our overall strategy. Several factors could positively or negatively impact our comparable sales results:

the general national, regional, and local economic conditions and corresponding impact on customer spending levels;
the introduction of new products or brands;
the location of new stores in existing store markets;
competition;
our ability to respond on a timely basis to changes in consumer preferences;
the effectiveness of our various merchandising and marketing activities; and
the number of new stores opened and the impact on the average age of all of our comparable stores.

Cost of sales includes:

the cost of merchandise sold, offset by vendor income that is not a reimbursement of specific, incremental, and identifiable costs;

17

Table of Contents

distribution costs including labor and related benefits, freight, rent, depreciation and amortization, real estate taxes, utilities, and insurance;
shipping and handling costs;
retail stores occupancy costs including rent, depreciation and amortization, real estate taxes, utilities, repairs and maintenance, insurance, and licenses;
salon services payroll and benefits; and
shrink and inventory valuation reserves.

Our cost of sales may be negatively impacted as we open new stores. Changes in our merchandise or channel mix may also have an impact on cost of sales. This presentation of items included in cost of sales may not be comparable to the way in which our competitors or other retailers compute their cost of sales.

Selling, general and administrative expenses include:

payroll, bonus, and benefit costs for retail store and corporate employees;
advertising and marketing costs, offset by vendor income that is a reimbursement of specific, incremental, and identifiable costs;
occupancy costs related to our corporate office facilities;
stock-based compensation expense;
depreciation and amortization for all assets, except those related to our retail stores and distribution operations, which are included in cost of sales; and
legal, finance, information systems, and other corporate overhead costs.

This presentation of items in selling, general and administrative expenses may not be comparable to the way in which our competitors or other retailers compute their selling, general and administrative expenses.

Pre-opening expenses include non-capital expenditures during the period prior to store opening for new, remodeled, and relocated stores including rent during the construction period for new and relocated stores, store set-up labor, management and employee training, and grand opening advertising.

Interest expense (income), net includes both interest expense and income. Interest expense includes interest costs and facility fees associated with our credit facility, which is structured as an asset-based lending instrument. Our credit facility interest is based on a variable interest rate structure which can result in increased cost in periods of rising interest rates. Interest income represents interest from cash equivalents and short-term investments with maturities of twelve months or less from the date of purchase.

Income tax expense reflects the federal statutory tax rate and the weighted average state statutory tax rate for the states in which we operate stores.

Results of operations

Our quarterly periods are the 13 weeks ending on the Saturday closest to April 30, July 31, October 31, and January 31. The Company’s third quarter in fiscal 2022 and 2021 ended on October 29, 2022 and October 30, 2021, respectively. Our quarterly results of operations have varied in the past and are likely to do so again in the future. As such, we believe that period-to-period comparisons of our results of operations should not be relied upon as an indication of our future performance.

18

Table of Contents

The following tables present the components of our consolidated results of operations for the periods indicated:

13 Weeks Ended

39 Weeks Ended

October 29,

October 30,

October 29,

October 30,

(Dollars in thousands)

2022

    

2021

    

2022

    

2021

Net sales

$

2,338,793

$

1,995,775

$

6,981,807

$

5,901,501

Cost of sales

1,375,976

1,206,301

4,149,800

3,560,276

Gross profit

962,817

789,474

2,832,007

2,341,225

Selling, general and administrative expenses

597,164

503,403

1,632,593

1,411,577

Pre-opening expenses

3,797

1,832

8,422

7,778

Operating income

361,856

284,239

1,190,992

921,870

Interest expense (income), net

(849)

413

(556)

1,196

Income before income taxes

362,705

283,826

1,191,548

920,674

Income tax expense

88,120

68,537

289,891

224,203

Net income

$

274,585

$

215,289

$

901,657

$

696,471

Other operating data:

Number of stores end of period

1,343

1,302

1,343

1,302

Comparable sales

14.6%

25.8%

15.6%

47.1%

13 Weeks Ended

39 Weeks Ended

October 29,

October 30,

October 29,

October 30,

(Percentage of net sales)

2022

    

2021

    

2022

    

2021

Net sales

100.0%

100.0%

100.0%

100.0%

Cost of sales

58.8%

60.4%

59.4%

60.3%

Gross profit

41.2%

39.6%

40.6%

39.7%

Selling, general and administrative expenses

25.5%

25.2%

23.4%

23.9%

Pre-opening expenses

0.2%

0.1%

0.1%

0.1%

Operating income

15.5%

14.2%

17.1%

15.6%

Interest expense (income), net

(0.0%)

0.0%

(0.0%)

0.0%

Income before income taxes

15.5%

14.2%

17.1%

15.6%

Income tax expense

3.8%

3.4%

4.2%

3.8%

Net income

11.7%

10.8%

12.9%

11.8%

19

Table of Contents

Comparison of 13 weeks ended October 29, 2022 to 13 weeks ended October 30, 2021

Net sales

Net sales increased $343.0 million or 17.2%, to $2.3 billion for the 13 weeks ended October 29, 2022, compared to $2.0 billion for the 13 weeks ended October 30, 2021. The net sales increase was primarily due to the favorable impact from the continued resilience of the beauty category, retail price increases, the impact of new brands and product innovation, and an increase of $20.2 million in other revenue compared to the 13 weeks ended October 30, 2021. The total comparable sales increase of 14.6% during the 13 weeks ended October 29, 2022 was driven by a 10.7% increase in transactions and a 3.5% increase in average ticket.

Gross profit

Gross profit increased $173.3 million or 22.0%, to $962.8 million for the 13 weeks ended October 29, 2022, compared to $789.5 million for the 13 weeks ended October 30, 2021. Gross profit as a percentage of net sales increased to 41.2% for the 13 weeks ended October 29, 2022, compared to 39.6% for the 13 weeks ended October 30, 2021. The increase in gross profit margin was primarily due to leverage of fixed costs, strong growth in other revenue, and higher merchandise margin, partially offset by higher inventory shrink.

Selling, general and administrative expenses

Selling, general and administrative (SG&A) expenses increased $93.8 million or 18.6%, to $597.2 million for the 13 weeks ended October 29, 2022, compared to $503.4 million for the 13 weeks ended October 30, 2021. SG&A expenses as a percentage of net sales increased to 25.5% for the 13 weeks ended October 29, 2022, compared to 25.2% for the 13 weeks ended October 30, 2021, primarily due to deleverage in store payroll and benefits and corporate overhead due to strategic investments, partially offset by lower marketing expenses.

Pre-opening expenses

Pre-opening expenses increased $2.0 million to $3.8 million for the 13 weeks ended October 29, 2022 compared to $1.8 million for the 13 weeks ended October 30, 2021.

Interest expense (income), net

Interest income, net was $0.8 million for the 13 weeks ended October 29, 2022 compared to interest expense, net of $0.4 million for the 13 weeks ended October 30, 2021. Interest income represents interest from cash equivalents and short-term investments with maturities of twelve months or less from the date of purchase. Interest expense represents interest on borrowings and fees related to the credit facility. We did not have any outstanding borrowings on our credit facility as of October 29, 2022, January 29, 2022, and October 30, 2021.

Income tax expense

Income tax expense of $88.1 million for the 13 weeks ended October 29, 2022 represents an effective tax rate of 24.3%, compared to $68.5 million of tax expense representing an effective tax rate of 24.1% for the 13 weeks ended October 30, 2021.

Net income

Net income increased $59.3 million or 27.5%, to $274.6 million for the 13 weeks ended October 29, 2022, compared to $215.3 million for the 13 weeks ended October 30, 2021. The increase in net income is primarily due to the $173.3 million increase in gross profit, partially offset by the $93.8 million increase in SG&A expenses and the $19.6 million increase in income taxes.

20

Table of Contents

Comparison of 39 weeks ended October 29, 2022 to 39 weeks ended October 30, 2021

Net sales

Net sales increased $1.1 billion or 18.3%, to $7.0 billion for the 39 weeks ended October 29, 2022, compared to $5.9 billion for the 39 weeks ended October 30, 2021. The net sales increase was primarily due to the favorable impact from the continued resilience of the beauty category, retail price increases, the impact of new brands and product innovation, the easing of COVID-19 restrictions, and an increase of $59.6 million in other revenue compared to the 39 weeks ended October 30, 2021. The total comparable sales increase of 15.6% during the 39 weeks ended October 29, 2022 was driven by a 9.7% increase in transactions and a 5.4% increase in average ticket.

Gross profit

Gross profit increased $490.8 million or 21.0%, to $2.8 billion for the 39 weeks ended October 29, 2022, compared to $2.3 billion for the 39 weeks ended October 30, 2021. Gross profit as a percentage of net sales increased to 40.6% for the 39 weeks ended October 29, 2022, compared to 39.7% for the 39 weeks ended October 30, 2021. The increase in gross profit margin was primarily due to leverage of fixed costs, strong growth in other revenue, and favorable channel mix shifts, partially offset by lower merchandise margin and higher inventory shrink.

Selling, general and administrative expenses

SG&A expenses increased $221.0 million or 15.7%, to $1.6 billion for the 39 weeks ended October 29, 2022, compared to $1.4 billion for the 39 weeks ended October 30, 2021. SG&A expenses as a percentage of net sales decreased to 23.4% for the 39 weeks ended October 29, 2022, compared to 23.9% for the 39 weeks ended October 30, 2021, due to lower marketing expenses, partially offset by deleverage in corporate overhead primarily due to strategic investments.

Pre-opening expenses

Pre-opening expenses increased $0.6 million to $8.4 million for the 39 weeks ended October 29, 2022, compared to $7.8 million for the 39 weeks ended October 30, 2021.

Interest expense (income), net

Interest income, net was $0.6 million for the 39 weeks ended October 29, 2022 compared to interest expense, net of $1.2 million for the 39 weeks ended October 30, 2021. Interest income represents interest from cash equivalents and short-term investments with maturities of twelve months or less from the date of purchase. Interest expense represents interest on borrowings and fees related to the credit facility. We did not have any outstanding borrowings on our credit facility as of October 29, 2022, January 29, 2022, and October 30, 2021.

Income tax expense

Income tax expense of $289.9 million for the 39 weeks ended October 29, 2022 represents an effective tax rate of 24.3%, compared to $224.2 million of tax expense representing an effective tax rate of 24.4% for the 39 weeks ended October 30, 2021.

Net income

Net income increased $205.2 million or 29.5%, to $901.7 million for the 39 weeks ended October 29, 2022 compared to $696.5 million for the 39 weeks ended October 30, 2021. The increase in net income is primarily due to the $490.8 million increase in gross profit, partially offset by the $221.0 million increase in SG&A expenses and the $65.7 million increase in income taxes.

Liquidity and capital resources

Our primary sources of liquidity are cash and cash equivalents, cash flows from operations, and borrowings under our credit facility. The most significant components of our working capital are merchandise inventories and cash and cash

21

Table of Contents

equivalents reduced by related accounts payable, accrued liabilities and deferred revenue. As of October 29, 2022, January 29, 2022, and October 30, 2021, we had cash and cash equivalents of $250.6 million, $431.6 million, and $605.1 million, respectively.

Our primary cash needs are for rent, capital expenditures for new, remodeled, and relocated stores, increased merchandise inventories related to store expansion and new brand additions, supply chain improvements, share repurchases, and continued improvement in our information technology systems.

Our most significant ongoing short-term cash requirements relate primarily to funding operations (including expenditures for lease expenses, inventory, labor, distribution, advertising and marketing, and tax liabilities) as well as periodic spend for capital expenditures, investments, and share repurchases. Our working capital needs are greatest from August through November each year as a result of our inventory build-up during this period for the approaching holiday season.

Long-term cash requirements primarily relate to funding lease expenses and other purchase commitments.

We generally fund short-term and long-term cash requirements with cash from operating activities. We believe our primary sources of liquidity will satisfy our cash requirements over both the short-term (the next twelve months) and long-term.

Cash flows

We believe our ability to generate substantial cash from operating activities and readily secure financing at competitive rates are key strengths that give us significant flexibility to meet our short and long-term financial commitments.

The following table presents a summary of our cash flows for the 39 weeks ended October 29, 2022 and October 30, 2021:

39 Weeks Ended

October 29,

October 30,

(In thousands)

    

2022

    

2021

Net cash provided by operating activities

$

573,426

$

414,857

Net cash used in investing activities

(207,029)

(108,418)

Net cash used in financing activities

(547,329)

(747,381)

Operating activities

Operating activities consist of net income adjusted for certain non-cash items, including depreciation and amortization, non-cash lease expense, deferred income taxes, stock-based compensation expense, realized gains or losses on disposal of property and equipment, and the effect of working capital changes.

The increase in net cash provided by operating activities in the first 39 weeks of fiscal 2022 is mainly due to the increase in net income, lower spend on merchandise inventories, and timing of accrued liabilities, partially offset by timing of accounts payable and increase in deferred revenue compared to the first 39 weeks of fiscal 2021.

The increase in net income was primarily due to an increase in gross profit, partially offset by an increase in SG&A expenses and income taxes.

Merchandise inventories, net were $2.11 billion at October 29, 2022, compared to $1.92 billion at October 30, 2021, representing an increase of $198.3 million or 10.3%. The change in total inventory is primarily due to the following:

$91 million increase due to new key brand launches;
$60 million increase due to the addition of 41 net new stores opened since October 30, 2021; and
$47 million increase due to inventory cost increases and inventory receipts to maintain strong in-stocks of key items to support expected demand.

22

Table of Contents

Investing activities

We have historically used cash primarily for new, remodeled, relocated, and refreshed stores, supply chain investments, short-term investments, and investments in information technology systems. Investment activities for capital expenditures were $204.0 million during the 39 weeks ended October 29, 2022, compared to $108.4 million during the 39 weeks ended October 30, 2021.

During the 39 weeks ended October 29, 2022, we opened 35 new stores, relocated 11 stores and remodeled eight stores, compared to the 39 weeks ended October 30, 2021, when we opened 42 new stores, relocated four stores and remodeled eight stores.

The increase in net cash used in investing activities in the first 39 weeks of fiscal 2022 compared to the first 39 weeks of fiscal 2021 was primarily due to more capital expenditures.

Our future investments will depend primarily on the number of new, remodeled, and relocated stores, information technology systems, and supply chain investments we undertake and the timing of these expenditures. Based on past performance and current expectations, we believe our sources of liquidity will be sufficient to fund future capital expenditures.

Financing activities

Financing activities include share repurchases, borrowing and repayment of our revolving credit facility, and capital stock transactions. Purchases of treasury shares represent the fair value of common shares repurchased from plan participants in connection with shares withheld to satisfy minimum statutory tax obligations upon the vesting of restricted stock.

The decrease in net cash used in financing activities in the first 39 weeks of fiscal 2022 compared to the first 39 weeks of fiscal 2021 was primarily due to a decrease in share repurchases.

We had no borrowings outstanding under the credit facility as of October 29, 2022, January 29, 2022, and October 30, 2021. The zero outstanding borrowings position continues to be due to a combination of factors including sales demand, overall performance of management initiatives including expense control, and inventory and other working capital reductions. We may require borrowings under the facility from time to time in future periods for unexpected business disruptions, to support our new store program, seasonal inventory needs, or share repurchases.

Share repurchase program

In March 2020, the Board of Directors authorized a share repurchase program (the 2020 Share Repurchase Program) pursuant to which the Company could repurchase up to $1.6 billion of the Company’s common stock. The 2020 Share Repurchase Program authorization revoked the previously authorized but unused amount of $177.8 million from the earlier share repurchase program. The 2020 Share Repurchase Program did not have an expiration date but provided for suspension or discontinuation at any time.

In March 2022, the Board of Directors authorized a new share repurchase program (the 2022 Share Repurchase Program) pursuant to which the Company may repurchase up to $2.0 billion of the Company’s common stock. The 2022 Share Repurchase Program revokes the previously authorized but unused amounts from the 2020 Share Repurchase Program. The 2022 Share Repurchase Program does not have an expiration date and may be suspended or discontinued at any time.

23

Table of Contents

A summary of common stock repurchase activity is presented in the following table:

39 Weeks Ended  

October 29,

October 30,

(Dollars in millions)

2022

    

2021

Shares repurchased

1,470,099

2,330,244

Total cost of shares repurchased

$

571.9

$

762.2

Credit facility

On March 11, 2020, we entered into Amendment No. 1 to the Second Amended and Restated Loan Agreement (as so amended, the Loan Agreement) with Wells Fargo Bank, National Association, as Administrative Agent, Collateral Agent and a Lender thereunder; Wells Fargo Bank, National Association and JPMorgan Chase Bank, N.A., as Lead Arrangers and Bookrunners; JPMorgan Chase Bank, N.A., as Syndication Agent and a Lender; PNC Bank, National Association, as Documentation Agent and a Lender; and the other lenders party thereto. The Loan Agreement matures on March 11, 2025, provides maximum revolving loans equal to the lesser of $1.0 billion or a percentage of eligible owned inventory and eligible owned receivables (which borrowing base may, at the election of the Company and satisfaction of certain conditions, include a percentage of qualified cash), contains a $50.0 million subfacility for letters of credit and allows the Company to increase the revolving facility by an additional $100.0 million, subject to the consent by each lender and other conditions. The Loan Agreement contains a requirement to maintain a fixed charge coverage ratio of not less than 1.0 to 1.0 during such periods when availability under the Loan Agreement falls below a specified threshold. Substantially all of the Company’s assets are pledged as collateral for outstanding borrowings under the Loan Agreement. Outstanding borrowings bear interest, at the Company’s election, at either a base rate plus a margin of 0% to 0.125% or the London Interbank Offered Rate plus a margin of 1.125% to 1.250%, with such margins based on the Company’s borrowing availability, and the unused line fee is 0.20% per annum.

As of October 29, 2022, January 29, 2022, and October 30, 2021, we had no borrowings outstanding under the credit facility.

As of October 29, 2022, we were in compliance with all terms and covenants of the Loan Agreement.

Seasonality

Our business is subject to seasonal fluctuation. Significant portions of our net sales and profits are realized during the fourth quarter of the fiscal year due to the holiday selling season. To a lesser extent, our business is also affected by Mother’s Day and Valentine’s Day. Any decrease in sales during these higher sales volume periods could have an adverse effect on our business, financial condition, or operating results for the entire fiscal year. Our quarterly results of operations have varied in the past and are likely to do so again in the future. As such, we believe that period-to-period comparisons of our results of operations should not be relied upon as an indication of our future performance.

Critical accounting policies and estimates

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements required the use of estimates and judgments that affect the reported amounts of our assets, liabilities, revenues, and expenses. Management bases estimates on historical experience and other assumptions it believes to be reasonable under the circumstances and evaluates these estimates on an on-going basis. Actual results may differ from these estimates. There have been no significant changes to the critical accounting policies and estimates included in our Annual Report on Form 10-K for the fiscal year ended January 29, 2022.

Item 3.Quantitative and Qualitative Disclosures About Market Risk

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates. We do not hold or issue financial instruments for trading purposes.

24

Table of Contents

Interest rate risk

We are exposed to interest rate risks primarily through borrowings under our credit facility. Interest on our borrowings is based upon variable rates. We did not have any outstanding borrowings on the credit facility as of October 29, 2022, January 29, 2022, and October 30, 2021.

Item 4.Controls and Procedures

Evaluation of disclosure controls and procedures over financial reporting

We have established disclosure controls and procedures to ensure that material information relating to the Company is made known to the officers who certify our financial reports and to the members of our senior management and Board of Directors.

Based on management’s evaluation as of October 29, 2022, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934), are effective to ensure that the information required to be disclosed by us in our reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in internal control over financial reporting

In the third quarter of 2022, we implemented a new enterprise resource planning (ERP) system, including a new general ledger accounting system. This implementation resulted in changes to our financial reporting processes and our internal control over financial reporting by automating certain manual procedures and standardizing business processes and reporting across the organization. Implementation of the new ERP system was the first phase in a multi-year rollout to upgrade our internal systems. Additional phases of the project will continue to be implemented over the next few years. We will continue to monitor our internal control over financial reporting under the new system, including evaluating the operating effectiveness of related key controls.

Except as described above, there were no changes to our internal controls over financial reporting during the 13 weeks ended October 29, 2022 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Part II - Other Information

Item 1.Legal Proceedings

See Note 6 to our consolidated financial statements, “Commitments and contingencies,” for information on legal proceedings.

Item 1A.Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended January 29, 2022, which could materially affect our business, financial condition, financial results, or future performance. There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended January 29, 2022.

25

Table of Contents

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth repurchases of our common stock during the third quarter of 2022:

Period

    

Total number

of shares

purchased (1)

    

Average
price paid
per share

    

Total number
of shares
purchased as
part of publicly
announced
plans or
programs (2)

    

Approximate

dollar value of

shares that may yet

be purchased

under plans or programs

(in thousands) (2)

July 31, 2022 to August 27, 2022

159,368

$

390.74

159,215

$

1,503,339

August 28, 2022 to September 24, 2022

150,868

419.97

150,280

1,440,240

September 25, 2022 to October 29, 2022

31,025

394.67

30,776

1,428,092

13 weeks ended October 29, 2022

341,261

404.02

340,271

1,428,092

(1)There were 340,271 shares repurchased as part of our publicly announced share repurchase program during the 13 weeks ended October 29, 2022 and there were 990 shares transferred from employees in satisfaction of minimum statutory tax withholding obligations upon the vesting of restricted stock during the period.
(2)In March 2022, we announced the 2022 Share Repurchase Program pursuant to which the Company may repurchase up to $2.0 billion of the Company’s common stock. The 2022 Share Repurchase Program revoked the previously authorized but unused amounts from the 2020 Share Repurchase Program. As of October 29, 2022, $1.4 billion remained available under the 2022 Share Repurchase Program.

Item 3.Defaults Upon Senior Securities

None

Item 4.Mine Safety Disclosures

None

Item 5.Other Information

None

26

Table of Contents

Item 6.Exhibits

The exhibits listed in the Exhibit Index below are filed as part of this Quarterly Report on Form 10-Q.

EXHIBIT INDEX

Incorporated by Reference

Exhibit
Number

Description of document

Filed Herewith

Form

Exhibit
Number

File

Number

Filing Date

3.1

Certificate of Incorporation of Ulta Beauty, Inc.

8-K

3.1

001-33764

1/30/2017

3.2

Bylaws of Ulta Beauty, Inc., as amended through June 3, 2020

8-K

3.2

001-33764

6/8/2020

31.1

Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002

X

31.2

Certification of the Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002

X

32

Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

X

101.INS

Inline XBRL Instance

X

101.SCH

Inline XBRL Taxonomy Extension Schema

X

101.CAL

Inline XBRL Taxonomy Extension Calculation

X

101.LAB

Inline XBRL Taxonomy Extension Labels

X

101.PRE

Inline XBRL Taxonomy Extension Presentation

X

101.DEF

Inline XBRL Taxonomy Extension Definition

X

104

Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).

27

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on December 1, 2022 on its behalf by the undersigned, thereunto duly authorized.

ULTA BEAUTY, INC.

By:

/s/ David C. Kimbell

David C. Kimbell
Chief Executive Officer and Director

By:

/s/ Scott M. Settersten

Scott M. Settersten
Chief Financial Officer, Treasurer and Assistant Secretary

28